Sigma
Device Ortho-Knee
PDI 10603295250777
General payments
$15,638,157
Research payments
$2,179,681
Through program year 2025, $15,638,157 in general payments and $2,179,681 in research payments were reported against Sigma (Ortho-Knee).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $2,842,056 | 35 |
| 2025 | Research | $445,625 | 26 |
| 2024 | General | $2,390,882 | 45 |
| 2024 | Research | $482,256 | 55 |
| 2023 | General | $2,766,262 | 71 |
| 2023 | Research | $454,075 | 49 |
| 2022 | General | $2,969,960 | 95 |
| 2022 | Research | $332,275 | 47 |
| 2021 | General | $4,668,998 | 141 |
| 2021 | Research | $465,450 | 34 |
Breakdown
The top 5 of 8 recipients; each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 7 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
387 general · 211 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.